机译:建立蛋白生物芯片以检测血清IgG抗体对IL-2和可溶性CD25的血液活性淋巴管症
Department of Pathology School of Basic Medicine Anhui Medical University;
Department of Pathology School of Basic Medicine Anhui Medical University;
Department of Pathology School of Basic Medicine Anhui Medical University;
Department of Pathology School of Basic Medicine Anhui Medical University;
Department of Pathology School of Basic Medicine Anhui Medical University;
Department of Pathology School of Basic Medicine Anhui Medical University;
Department of Pathology School of Basic Medicine Anhui Medical University;
Department of Pathology School of Basic Medicine Anhui Medical University;
Biochip; IL-2; sCD25; IgG antibody; Serum; HLH;
机译:建立蛋白生物芯片以检测血清IgG抗体对IL-2和可溶性CD25的血液活性淋巴管症
机译:抗CD25抗体daclizumab在具有吞噬性淋巴细胞组织细胞增生症的成年患者中的成功使用。
机译:严重脓毒症和血液活性淋巴管梭菌(HLH)患者高血清SCD25和SCD163诊断中的作用(HLH)
机译:与人血清,等离子体和滑膜液中的匹配对照相比,抗瓜氨酸蛋白抗体显示IgG型比变化
机译:丙二醛和卷烟烟气常见化学物质修饰的可溶性蛋白刺激小鼠模型中血清游离轻链而不是完整分子IgG的潜在次级反应。
机译:抗CD25抗体达克珠单抗在成年噬血细胞性淋巴组织细胞增生症患者中的成功使用
机译:在成年患者中成功地使用抗CD25抗体daclizumab,血小杂性淋巴管激会症